Skip to main navigation Skip to search Skip to main content

High-volume online hemodiafiltration versus high-flux hemodialysis: a short review of recent evidence and a discussion on clinical implementation

  • Peter J Blankestijn*
  • *Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

9 Downloads (Pure)

Abstract

Online hemodiafiltration (HDF) has received significant attention as a potentially superior dialysis modality compared to conventional high-flux hemodialysis for patients with end-stage kidney disease. The CONVINCE (CONvective VERSus diffusive dialysis in patients with End-stage kidney disease) trial, subsequent meta-analyses, and observational studies indicate that high-dose HDF (≥23 L convection per session) is associated with improved survival outcomes, particularly through reductions in cardiovascular and possibly also infection-related mortality. Additionally, emerging evidence suggests modest but meaningful benefits in health-related quality of life and symptom control. This comment synthesizes the current literature (2022-2025), highlighting clinical outcomes, patient-centered metrics, feasibility, cost-effectiveness, personalized treatment considerations, and implications for clinical practice. Additionally, practical prescription guidance is provided to assist nephrologists in achieving optimal convection volumes and clinical outcomes in routine clinical practice.

Original languageEnglish
Pages (from-to)875-879
Number of pages5
JournalKidney research and clinical practice
Volume44
Issue number6
DOIs
Publication statusPublished - Nov 2025

Keywords

  • Clinical trial
  • Hemodiafiltration
  • Hemodialysis
  • Mortality

Fingerprint

Dive into the research topics of 'High-volume online hemodiafiltration versus high-flux hemodialysis: a short review of recent evidence and a discussion on clinical implementation'. Together they form a unique fingerprint.

Cite this